BIOMAT Database Logo BIOMAT Database Logo

Rapid diagnosis of acute promyelocytic leukemia (PML): applicability of flow cytometry and PML protein immunofluorescence. 2004

Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071156 Promyelocytic Leukemia Protein A tripartite motif protein that contains three ZINC FINGERS, including a RING FINGER DOMAIN, at its N-terminal. Several nuclear and one cytoplasmic isoforms result from alternative splicing of the PML gene; most nuclear isoforms localize to subnuclear structures (PML nuclear bodies) that are disrupted in ACUTE PROMYELOCYTIC LEUKEMIA cells. RNF71 Protein,TRIM19 Protein
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias
D025521 Tumor Suppressor Proteins Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development. Growth Suppressor Proteins,Metastasis Suppressor Protein,Metastasis Suppressor Proteins,Tumor Suppressor Protein,Protein, Metastasis Suppressor,Protein, Tumor Suppressor,Proteins, Growth Suppressor,Proteins, Metastasis Suppressor,Proteins, Tumor Suppressor,Suppressor Protein, Metastasis,Suppressor Protein, Tumor

Related Publications

Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Evaluation of PML immunofluorescence, flow cytometric immunophenotypic analysis, and reverse transcriptase polymerase chain reaction for PML/RARa for rapid diagnosis of acute promyelocytic leukemia.
January 2011, Cancer,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein.
August 1995, Blood,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
July 2022, Cytometry. Part B, Clinical cytometry,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Role of flow cytometry in the diagnosis of acute promyelocytic leukemia.
June 2013, American journal of clinical pathology,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Microgranular acute promyelocytic leukemia diagnosed by flow cytometry.
August 1983, The New England journal of medicine,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
January 2002, The hematology journal : the official journal of the European Haematology Association,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Immunofluorescence staining with an antipromyelocytic leukemia antibody for a rapid diagnosis of acute promyelocytic leukemia.
March 2017, Hematology/oncology and stem cell therapy,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.
July 2021, Cytometry. Part B, Clinical cytometry,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
PML protein expression in hematopoietic and acute promyelocytic leukemia cells.
September 1993, Blood,
Matthew J Cullen, and Stephen J Richards, and Sheila J M O'Connor, and Helen Dickinson, and Carol Sharpe, and David M Swirsky, and Roger Owen
PML(NLS¯) protein: A novel marker for the early diagnosis of acute promyelocytic leukemia.
October 2017, Molecular medicine reports,
Copied contents to your clipboard!